153 related articles for article (PubMed ID: 2529134)
1. Dopamine D1 heteroreceptors on striatonigral axons are not stimulated by endogeneous dopamine either tonically or after amphetamine: evidence from terminal excitability.
Ryan LJ; Diana M; Young SJ; Groves PM
Exp Brain Res; 1989; 77(1):161-5. PubMed ID: 2529134
[TBL] [Abstract][Full Text] [Related]
2. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
Diana M; Young SJ; Groves PM
Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226
[TBL] [Abstract][Full Text] [Related]
4. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
5. D1 receptor activation enhances sciatic nerve stimulation-induced inhibition of nigrostriatal dopamine neurons.
Kelland MD; Freeman AS; Chiodo LA
Synapse; 1989; 3(4):339-45. PubMed ID: 2525823
[TBL] [Abstract][Full Text] [Related]
6. Modulation of dopaminergic terminal excitability by D1 selective agents.
Diana M; Young SJ; Groves PM
Neuropharmacology; 1989 Jan; 28(1):99-101. PubMed ID: 2522599
[TBL] [Abstract][Full Text] [Related]
7. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
8. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway.
Martin LP; Waszczak BL
J Neurosci; 1994 Jul; 14(7):4494-506. PubMed ID: 7913124
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-regulated phosphorylation of synaptic vesicle-associated proteins in rat neostriatum and substantia nigra.
Walaas SI; Sedvall G; Greengard P
Neuroscience; 1989; 29(1):9-19. PubMed ID: 2496331
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
11. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
Kelland MD; Freeman AS; Chiodo LA
Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1 agonist SKF 38393 increases the state of phosphorylation of ARPP-21 in substantia nigra.
Tsou K; Girault JA; Greengard P
J Neurochem; 1993 Mar; 60(3):1043-6. PubMed ID: 8436957
[TBL] [Abstract][Full Text] [Related]
13. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
Carlson JH; Bergstrom DA; Weick BG; Walters JR
Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
[TBL] [Abstract][Full Text] [Related]
15. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
16. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
Santiago M; Westerink BH
Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
[TBL] [Abstract][Full Text] [Related]
17. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects.
Timmerman W; Abercrombie ED
Synapse; 1996 Aug; 23(4):280-91. PubMed ID: 8855513
[TBL] [Abstract][Full Text] [Related]
19. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
20. Modulation of GABA release by dopamine in the substantia nigra.
Matuszewich L; Yamamoto BK
Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
